CLINICAL_TRIALS
trial_result
· 2023-08-21
Clinical Trial Update: Safety, Tolerability and the Pharmacokinetics of Ridinilazole in Adolescent Subjects [Phase 3]
Summary
Phase 3 safety and pharmacokinetics update for ridinilazole in adolescents; trial terminated with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Summit Therapeutics | Conditions: Clostridioides Difficile Infection | Phase 3 | Status: TERMINATED | Results posted: 2023-08-21